MVT-2163

DRUG2 trials

Sponsors

BioNTech Research & Development, Inc., Memorial Sloan Kettering Cancer Center

Conditions

Pancreatic CancerPancreatic CarcinomaTumors That Express CA19-9

Phase 1

Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

TerminatedNCT02687230

BioNTech Research & Development, Inc.Pancreatic Carcinoma, Tumors That Express CA19-9

Start: 2016-07-11End: 2017-05-05Updated: 2021-08-31

Study of a New Technique for Imaging Pancreatic Cancer

CompletedNCT04883775

Memorial Sloan Kettering Cancer CenterPancreatic Cancer, Tumors That Express CA19-9

Start: 2021-05-10End: 2025-01-27Updated: 2025-01-30

Related Papers

Abstract I18: Retooling a blood-based biomarker into a theranostic agent

Cancer Research2019-12-13

Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model.

2018-10-0118 citations